Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of CORT Corcept Therapeutics | 65.6% in 12m

Compare CORT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Corcept Therapeutics with its related Sector/Index XLV

Compare Corcept Therapeutics with its related Sector/Index XLV

Performance Duell CORT vs XLV

TimeFrame CORT XLV
1 Week 2.32% 0.70%
1 Month 21.8% -2.43%
3 Months 44.8% 3.84%
6 Months 102.3% 11.10%
12 Months 65.6% 19.58%
YTD 93.9% 11.38%
Rel. Perf. 1m 2.20
Rel. Perf. 3m 3.27
Rel. Perf. 6m 5.71
Rel. Perf. 12m 3.14
Spearman 1m 0.78 -0.540
Spearman 3m 0.76 0.537

Is Corcept Therapeutics a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, Corcept Therapeutics (NASDAQ:CORT) is currently (October 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 69.24 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CORT as of October 2024 is 53.46. This means that CORT is currently undervalued and has a potential upside of +14.13% (Margin of Safety).

Is CORT a buy, sell or hold?

  • Strong Buy: 3
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
Corcept Therapeutics has received a consensus analysts rating of 4.60. Therefor, it is recommend to buy CORT.
Values above 0%: CORT is performing better - Values below 0%: CORT is underperforming

Compare CORT with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 1.17% 18.43% 86.67% 28.98%
US NASDAQ 100 QQQ 2.00% 17.89% 88.12% 29.56%
US Dow Jones Industrial 30 DIA 0.72% 19.02% 88.05% 36.28%
German DAX 40 DBXD 0.08% 17.14% 94.58% 35.13%
UK FTSE 100 ISFU 1.44% 22.71% 91.42% 41.39%
Shanghai Shenzhen CSI 300 CSI 300 14.17% 2.96% 91.49% 55.53%
Hongkong Hang Seng HSI 6.96% 10.30% 80.08% 55.91%
Japan Nikkei 225 EXX7 2.42% 17.44% 101.14% 42.31%
India NIFTY 50 INDA 2.46% 23.70% 91.13% 36.67%
Brasil Bovespa EWZ 4.29% 27.09% 107.11% 64.68%

CORT Corcept Therapeutics vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 1.66% 17.72% 88.30% 28.62%
Consumer Discretionary XLY 1.87% 18.57% 88.24% 39.40%
Consumer Staples XLP 0.56% 23.34% 88.00% 40.91%
Energy XLE 3.74% 17.20% 106.51% 64.58%
Financial XLF -1.10% 17.37% 83.77% 21.73%
Health Care XLV 1.62% 24.19% 91.23% 45.99%
Industrial XLI 0.33% 16.13% 88.33% 26.19%
Materials XLB 0.32% 18.32% 93.68% 38.15%
Real Estate XLRE 0.13% 23.46% 79.23% 29.77%
Technology XLK 1.99% 17.44% 88.45% 28.21%
Utilities XLU 0.90% 19.21% 73.72% 24.99%
Aerospace & Defense XAR 1.11% 16.60% 81.12% 27.95%
Biotech XBI 0.04% 23.69% 87.16% 20.35%
Homebuilder XHB 0.89% 18.88% 81.70% -5.21%
Retail XRT 0.27% 19.48% 92.72% 36.29%

CORT Corcept Therapeutics vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 6.32% 19.11% 113.22% 74.44%
Natural Gas UNG 10.45% 27.48% 103.25% 116.79%
Gold GLD 0.86% 18.72% 91.03% 29.60%
Silver SLV -0.18% 19.48% 93.62% 28.53%
Copper CPER 4.93% 19.43% 102.62% 42.84%

Returns of CORT vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 2.40% 27.79% 93.42% 48.74%
iShares High Yield Corp. Bond HYG 2.14% 21.57% 94.31% 48.17%
Does Corcept Therapeutics outperform its market, is CORT a Sector Leader?
Yes, over the last 12 months Corcept Therapeutics (CORT) made 65.57%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 19.58%.
Over the last 3 months CORT made 44.79%, while XLV made 3.84%.
Period CORT XLV S&P 500
1 Month 21.76% -2.43% 3.33%
3 Months 44.79% 3.84% 3.57%
12 Months 65.57% 19.58% 36.59%